Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Echo Water Unveils the Echo One: An Ultra-Pure Hydrogen Water System
-
GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline
-
TransactionTree Appoints Kevin Saum as Chief Executive Officer to Lead Next Phase of Growth
-
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
-
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and He
-
VIP Play, Inc. Announces Strategic Entry into Daily Fantasy Sports Market
-
MSC Income Fund Announces Fourth Quarter 2025 Private Loan Portfolio Activity
-
Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development
-
Enhanced Digital Group Announces Series A Financing
-
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
-
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
-
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
-
Main Street Announces Fourth Quarter 2025 Private Loan Portfolio Activity
-
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
-
Cloopen Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
-
Vertiv Expects Powering Up for AI, Digital Twins and Adaptive Liquid Cooling to Shape Data Center Design and Operations
-
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
-
The N2 Company Celebrates 10 Years of Giving, $30 Million Donated to Fight Human Trafficking
-
PlusAI on Track to Launch Factory-Built Commercial Autonomous Trucks Next Year
-
Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
-
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
-
Vizgen Announces $48 Million Financing
-
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
-
JOYBEES WINS TWO GLOBAL FOOTWEAR AWARDS
-
NIQ and Kodiak Announce Retail Measurement Agreement to Drive Breakfast Category Growth
-
Lantronix to Attend 28th Annual Needham Growth Conference on Jan. 13, 2026
-
RELEX Solutions Launches Deal Management for Smarter Collaborative Promotion Planning
-
Lumexa Imaging Achieves Record De Novo Expansion in 2025
-
Tanger Announces Pricing of Upsized Exchangeable Senior Notes Offering
-
K1x and Juno Announce Strategic Partnership to Provide Industry-Leading Tax Automation
-
U.S. Army Selects Striveworks for AI Test and Evaluation
-
Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease
-
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
-
Miller Lite Unveils New Creative Platform, "Legendary Moments Start with a Lite," Starring Christopher Walken
-
Concord Appoints Chris Baker as Executive Chairman
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
-
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
-
Aurora Mobile Congratulates Zhipu on Successful Hong Kong Listing
-
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
-
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
-
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
-
Woof Gang Achieves Record Growth in 2025
-
Anika Therapeutics Announces Leadership Transition
-
ONAR Completes Sale of Certain Legacy Assets in a Secured $1.5 Million Seller-Financed Transaction
-
Transpire Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
-
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
-
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
-
Troilus Delivers on Key Development Milestones in 2025 and Enters a Pivotal Transition Year in 2026
-
Kinross to provide update on Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects
